Related references
Note: Only part of the references are listed.Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes
Liliana M. Sanmarco et al.
NATURE (2021)
Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors
Darren C. Phillips et al.
CANCER RESEARCH (2021)
Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist
Chiara Boccellato et al.
CELL DEATH & DISEASE (2021)
Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism
Vesna Vetma et al.
CELL DEATH AND DIFFERENTIATION (2020)
ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
Priya Kumthekar et al.
CLINICAL CANCER RESEARCH (2020)
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
William M. Pardridge
FRONTIERS IN AGING NEUROSCIENCE (2020)
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Mihalis S. Kariolis et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Physiological blood-brain transport is impaired with age by a shift in transcytosis
Andrew C. Yang et al.
NATURE (2020)
On the shuttling across the blood-brain barrier via tubule formation: Mechanism and cargo avidity bias
Xiaohe Tian et al.
SCIENCE ADVANCES (2020)
RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer
Hajrah Khawaja et al.
CELL DEATH & DISEASE (2020)
Phase 1, first-in-human study of TRAIL receptor agonist fusion protein ABBV-621.
Mark J. Ratain et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Molecular Mode of Action of TRAIL Receptor Agonists-Common Principles and Their Translational Exploitation
Harald Wajant
CANCERS (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood-brain barrier and target glioma
Xuemei Ji et al.
AMB EXPRESS (2019)
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment
Jessica Wagner et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier invitro is dependent on its binding affinity
Arsalan S. Haqqani et al.
JOURNAL OF NEUROCHEMISTRY (2018)
CellProfiler 3.0: Next-generation image processing for biology
Claire McQuin et al.
PLOS BIOLOGY (2018)
Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
Frank A. Lincoln et al.
CELL DEATH & DISEASE (2018)
Superior Properties of Fc-comprising scTRAIL Fusion Proteins
Meike Hutt et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity
Carl I. Webster et al.
PAIN (2017)
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Greta Hultqvist et al.
THERANOSTICS (2017)
Sorting Tubules Regulate Blood-Brain Barrier Transcytosis
Roberto Villasenor et al.
CELL REPORTS (2017)
Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier
Shu Yang et al.
PLOS ONE (2017)
Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier
Steffen E. Storck et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Onto better TRAILs for cancer treatment
D. de Miguel et al.
CELL DEATH AND DIFFERENTIATION (2016)
Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells
Tugba Bagci-Onder et al.
BRAIN (2015)
Brain endothelial TAK1 and NEMO safeguard the neurovascular unit
Dirk A. Ridder et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines
R. Polanski et al.
CELL DEATH & DISEASE (2015)
Immuno-LipoTRAIL: Targeted Delivery of TRAIL-Functionalized Liposomal Nanoparticles
Oliver Seifert et al.
BIOCONJUGATE CHEMISTRY (2014)
Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties
Michel Demeule et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
Nga Bien-Ly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Comparison of Five Peptide Vectors for Improved Brain Delivery of the Lysosomal Enzyme Arylsulfatase A
Annika Boeckenhoff et al.
JOURNAL OF NEUROSCIENCE (2014)
Tetravalent Antibody-scTRAIL Fusion Proteins with Improved Properties
Oliver Seifert et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Retro-Inverso Isomer of Angiopep-2: A Stable D-Peptide Ligand Inspires Brain-Targeted Drug Delivery
Xiaoli Wei et al.
MOLECULAR PHARMACEUTICS (2014)
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
Jens Niewoehner et al.
NEURON (2014)
APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fcγ Receptors
Christian Gieffers et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Improved survival time trends for glioblastoma using the SEER 17 population-based registries
Matthew Koshy et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)
Ross Booth et al.
LAB ON A CHIP (2012)
Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity
M. Siegemund et al.
CELL DEATH & DISEASE (2012)
Glycemic Control and Chronic Dosing of Rhesus Monkeys with a Fusion Protein of Iduronidase and a Monoclonal Antibody Against the Human Insulin Receptor
Ruben J. Boado et al.
DRUG METABOLISM AND DISPOSITION (2012)
Quantitative Proteomics of Transporter Expression in Brain Capillary Endothelial Cells Isolated from P-Glycoprotein (P-gp), Breast Cancer Resistance Protein (Bcrp), and P-gp/Bcrp Knockout Mice
Sagar Agarwal et al.
DRUG METABOLISM AND DISPOSITION (2012)
Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma
Shixian Huang et al.
BIOMATERIALS (2011)
CHO Cell Expression, Long-Term Stability, and Primate Pharmacokinetics and Brain Uptake of an IgG-Paroxonase-1 Fusion Protein
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
Ramzi Shawahna et al.
MOLECULAR PHARMACEUTICS (2011)
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Transport characteristics of a novel peptide platform for CNS therapeutics
Yanick Bertrand et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Survival comparison between glioblastoma multiforme and other incurable cancers
B. Tran et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain
Kun Shao et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5
Marine E. Gasparian et al.
APOPTOSIS (2009)
Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer
Fancy C. Thomas et al.
PHARMACEUTICAL RESEARCH (2009)
Phosphatidylinostol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis
Daniela Opel et al.
CANCER RESEARCH (2008)
Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis
Holger Hetschko et al.
FEBS JOURNAL (2008)
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
Michel Demeule et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Identification and design of peptides as a new drug delivery system for the brain
Michel Demeule et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Death receptor expression and function at the human blood brain barrier
Karolina Wosik et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells
Rachel C. Brown et al.
BRAIN RESEARCH (2007)
Molecular Trojan horses for blood-brain barrier drug delivery
William M. Pardridge
CURRENT OPINION IN PHARMACOLOGY (2006)
The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology
Giorgio Zauli et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
TRAIL and apoptosis induction by TNF-family death receptors
SL Wang et al.
ONCOGENE (2003)
Transcytosis: Crossing cellular barriers
PL Tuma et al.
PHYSIOLOGICAL REVIEWS (2003)
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
S Fulda et al.
NATURE MEDICINE (2002)
Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis
B Hilliard et al.
JOURNAL OF IMMUNOLOGY (2001)
Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types
XD Zhang et al.
FEBS LETTERS (2000)
Share Paper
